Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 10/20 | 0.54 |
| ▸ | LPL | P06858 | 9/20 | 0.54 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.34 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.32 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.31 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.31 |
| ▸ | P4HB | P07237 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.31 |
| ▸ | SNCA | P37840 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14506122 | 0.93 | LIPG (0.64) | LIPGLPLDGAT1IRAK4PDGFRB | |
| SCHEMBL14506121 | 0.89 | LIPG (0.60) | LIPGLPLDGAT1IRAK4PDK2 | |
| SCHEMBL17143469 | 0.89 | LIPG (0.57) | LIPGLPLDGAT1PDK2KDM4E | |
| SCHEMBL24257896 | 0.89 | LIPG (0.57) | LIPGLPLDGAT1PDK2KDM4E | |
| SCHEMBL17143472 | 0.89 | LIPG (0.57) | LIPGLPLDGAT1PDK2KDM4E | |
| SCHEMBL16670290 | 0.89 | LIPG (0.52) | LIPGLPLDGAT1IRAK4PDK2 | |
| SCHEMBL13414970 | 0.88 | LIPG (0.67) | LIPGLPLDGAT1PDGFRBKDR | |
| SCHEMBL17143248 | 0.87 | LIPG (0.48) | LIPGLPLDGAT1PDK2KDM4E | |
| SCHEMBL29892359 | 0.87 | LIPG (0.47) | LIPGLPLDGAT1IRAK4KDM4E | |
| SCHEMBL2618788 | 0.87 | LIPG (0.47) | LIPGLPLDGAT1IRAK4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106164055-B | Heterocyclic compound and organic light-emitting device comprising same | 株式会社LG化学 | 2019-12-27 | — | — | CN | disclosed |
| US-10381572-B2 | Heterocyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2019-08-13 | — | — | US | disclosed |
| US-20170018718-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-01-19 | — | — | US | disclosed |
| WO-2015152651-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2015-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10381572-B2 | Heterocyclic compound and organic light-emitting element comprising same | CRY1, CRY2, PER2 | LIPG 2731/4885LPL 2062/4885DGAT1 859/4885 |
| US-20170018718-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | LIPG 2731/4885LPL 2062/4885DGAT1 859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.